Cash flow Nahdi Medical Company

Equities

4164

SA15HG521213

Drug Retailers

Delayed Saudi Arabian S.E. Other stock markets 11:23:06 08/02/2026 GMT			5-day change	1st Jan Change
101.00 ^SAR	+0.10%		+2.64%	+6.21%

02-02	Morgan Stanley Begins Nahdi Medical's Coverage at Overweight	MT
01-29	Citi Upgrades Nahdi Medical to Buy	MT

75e7294f6e186eac.j_oKNnS6b_-_G1HHAXRpHC4j-b-fqonZpbm2HK9Dfr4.xalfX0T-BJX7LBWVVT8sbx1arN3-4eDgyerYZsg3F8vuq20GGfYGuv5SOg

Published financial data: NAHDI MEDICAL COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	8.64B	8.07B	8.62B	8.71B	9.45B
Total Revenues	8.64B	8.07B	8.62B	8.71B	9.45B
Cost of Goods Sold, Total	5.45B	4.82B	5.17B	5.28B	6B
Gross Profit	3.19B	3.25B	3.45B	3.44B	3.44B
Selling General & Admin Expenses, Total	2.27B	2.4B	2.5B	2.5B	2.6B
Provision for Bad Debts	-18M	-	-	-	-
Other Operating Expenses	-24.89M	-58.06M	-48.8M	-23.7M	-27.91M
Other Operating Expenses, Total	2.23B	2.34B	2.45B	2.47B	2.57B
Operating Income	968M	906M	1B	961M	872M
Interest Expense, Total	-57.5M	-78.88M	-79.38M	-50.46M	-73.72M
Interest And Investment Income	5.45M	2.96M	12.13M	56.82M	50.8M
Net Interest Expenses	-52.05M	-75.92M	-67.25M	6.36M	-22.92M
Currency Exchange Gains (Loss)	-	-	-	7.91M	8.34M
Other Non Operating Income (Expenses)	-	7.61M	19.56M	-31.47M	-25.67M
EBT, Excl. Unusual Items	916M	838M	952M	944M	831M
Gain (Loss) On Sale Of Assets	1.13M	148K	-17.37M	217K	1.54M
Asset Writedown	-22.6M	19.49M	3.16M	498K	1.6M
EBT, Incl. Unusual Items	894M	857M	938M	944M	835M
Income Tax Expense	45.33M	44.74M	50.11M	51.63M	13.82M
Earnings From Continuing Operations	849M	813M	888M	893M	821M
Net Income to Company	849M	813M	888M	893M	821M
Net Income - (IS)	849M	813M	888M	893M	821M
Net Income to Common Incl Extra Items	849M	813M	888M	893M	821M
Net Income to Common Excl. Extra Items	849M	813M	888M	893M	821M
Per Share Items
Net EPS - Basic	8.49	6.25	6.83	6.87	6.31
Basic EPS - Continuing Operations	8.49	6.25	6.83	6.87	6.31
Basic Weighted Average Shares Outstanding	100M	130M	130M	130M	130M
Net EPS - Diluted	8.49	6.25	6.83	6.87	6.31
Diluted EPS - Continuing Operations	8.49	6.25	6.83	6.87	6.31
Diluted Weighted Average Shares Outstanding	100M	130M	130M	130M	130M
Normalized Basic EPS	5.72	4.03	4.58	4.54	4
Normalized Diluted EPS	5.72	4.03	4.58	4.54	4
Dividend Per Share	-	-	5.31	5.5	5.5
Payout Ratio	63.01	155.07	33.82	80.1	87.12
Supplemental Items
EBITDA	1.11B	1.07B	1.19B	1.18B	1.13B
EBITA	968M	906M	1B	961M	872M
EBIT	968M	906M	1B	961M	872M
EBITDAR	1.12B	-	1.2B	1.22B	1.15B
Effective Tax Rate - (Ratio)	5.07	5.22	5.34	5.47	1.66
Normalized Net Income	572M	524M	595M	590M	520M
Interest on Long-Term Debt	47.19M	47.63M	50.47M	50.46M	73.72M
Non-Cash Pension Expense	13.34M	7.06M	10.71M	15.94M	6.95M
Supplemental Operating Expense Items
Advertising Expense	75.69M	54.53M	67.81M	66.36M	59.61M
Selling and Marketing Expenses	1.95B	2.12B	2.21B	2.2B	2.29B
General and Administrative Expenses	311M	277M	293M	296M	304M
Net Rental Expense, Total	10.32M	-	7.45M	36.61M	20.09M
Imputed Operating Lease Interest Expense	3.92M	-	3.74M	12.62M	8.76M
Imputed Operating Lease Depreciation	6.4M	-	3.71M	24M	11.33M
Maintenance & Repair Expenses, Total	55.31M	59.3M	70.18M	86.52M	91.39M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.01B	401M	1.08B	910M	957M
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	1.01B	401M	1.08B	910M	957M
Accounts Receivable, Total	94.78M	140M	130M	173M	136M
Notes Receivable	40.02M	45.33M	48.41M	57.13M	-
Total Receivables	135M	186M	179M	230M	136M
Inventory	1.18B	1.12B	1.18B	1.41B	1.71B
Prepaid Expenses	39.58M	48.35M	56.92M	50.64M	111M
Other Current Assets, Total	94.95M	47.89M	68.97M	159M	197M
Total Current Assets	2.46B	1.8B	2.56B	2.76B	3.11B
Gross Property Plant And Equipment	2.69B	3.07B	3.03B	3.44B	4.08B
Accumulated Depreciation	-727M	-860M	-950M	-1.13B	-1.36B
Net Property Plant And Equipment	1.97B	2.21B	2.08B	2.31B	2.72B
Other Intangibles, Total	41.57M	44.21M	47.06M	51.17M	68.62M
Other Long-Term Assets, Total	184M	230M	254M	254M	274M
Total Assets	4.65B	4.29B	4.94B	5.37B	6.17B
Liabilities
Accounts Payable, Total	443M	484M	637M	894M	1.25B
Accrued Expenses, Total	273M	213M	224M	289M	265M
Current Portion of Leases	376M	367M	376M	304M	383M
Current Income Taxes Payable	98.05M	96.87M	107M	113M	76.97M
Unearned Revenue Current, Total	37.51M	18.18M	13M	4.33M	12.62M
Other Current Liabilities	172M	106M	152M	26.76M	19.62M
Total Current Liabilities	1.4B	1.29B	1.51B	1.63B	2.01B
Long-Term Leases	829M	992M	792M	871M	1.15B
Pension & Other Post Retirement Benefits	329M	387M	381M	392M	420M
Other Non Current Liabilities	14.38M	19.09M	20.04M	14.79M	14.62M
Total Liabilities	2.57B	2.68B	2.7B	2.91B	3.59B
Common Stock, Total	1B	1.3B	1.3B	1.3B	1.3B
Retained Earnings	1.08B	304M	944M	1.16B	1.29B
Comprehensive Income and Other	-161K	-185K	-395K	-843K	-74.26K
Total Common Equity	2.08B	1.6B	2.24B	2.46B	2.59B
Total Equity	2.08B	1.6B	2.24B	2.46B	2.59B
Total Liabilities And Equity	4.65B	4.29B	4.94B	5.37B	6.17B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	100M	130M	130M	130M	130M
ECS Total Common Shares Outstanding	100M	130M	130M	130M	130M
Book Value / Share	20.79	12.34	17.26	18.94	19.89
Tangible Book Value	2.04B	1.56B	2.2B	2.41B	2.52B
Tangible Book Value Per Share	20.37	12	16.89	18.55	19.37
Total Debt	1.21B	1.36B	1.17B	1.17B	1.53B
Net Debt	197M	958M	91.79M	265M	573M
Debt Equivalent of Unfunded Proj. Benefit Obligation	329M	387M	381M	392M	420M
Debt Equivalent Oper. Leases	82.56M	-	59.61M	293M	161M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	-	-	-	-
Inventories - Others	1.38B	1.24B	1.33B	1.51B	1.82B
Land - (BS)	103M	74.43M	58.17M	58.17M	58.17M
Buildings, Total	46.41M	44.42M	247M	252M	281M
Machinery, Total	331M	368M	372M	440M	505M
Full Time Employees	6.18K	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	13.34M	6.71M	8.41M	3.92M	3.72M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	849M	813M	888M	893M	821M
Depreciation & Amortization - CF	492M	547M	575M	595M	676M
Amortization of Goodwill and Intangible Assets - (CF)	525K	-	1.17M	-	-
Depreciation & Amortization, Total	493M	547M	576M	595M	676M
Amortization of Deferred Charges, Total - (CF)	17.01M	24.2M	20.89M	23.13M	27.52M
(Gain) Loss From Sale Of Asset	-1.13M	-26.48K	17.42M	-217K	-1.54M
Asset Writedown & Restructuring Costs	22.6M	-19.49M	-10.11M	-498K	-1.6M
Provision and Write-off of Bad Debts	-18M	5.87M	3.19M	-4.49M	-193K
Other Operating Activities, Total	226M	51.93M	120M	18.27M	-18.16M
Change In Accounts Receivable	62.36M	-47.65M	6.89M	-38.16M	37.54M
Change In Inventories	-189M	55.27M	-127M	-215M	-334M
Change In Accounts Payable	-70.25M	43.74M	153M	257M	354M
Change in Other Net Operating Assets	194M	-92.06M	19.44M	-159M	-69.38M
Cash from Operations	1.59B	1.38B	1.67B	1.37B	1.49B
Capital Expenditure	-296M	-283M	-250M	-354M	-340M
Sale of Property, Plant, and Equipment	13.82M	7.1M	103K	254K	1.57M
Sale (Purchase) of Intangible assets	-23.97M	-23.89M	-24.97M	-30.65M	-44.97M
Investment in Marketable and Equity Securities, Total	203M	-	-	-	-
Other Investing Activities, Total	-	-	-	-	54.92M
Cash from Investing	-103M	-299M	-275M	-384M	-328M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-312M	-430M	-417M	-436M	-402M
Total Debt Repaid	-312M	-430M	-417M	-436M	-402M
Common Dividends Paid	-535M	-1.26B	-300M	-715M	-715M
Common & Preferred Stock Dividends Paid	-535M	-1.26B	-300M	-715M	-715M
Cash from Financing	-847M	-1.69B	-717M	-1.15B	-1.12B
Foreign Exchange Rate Adjustments	-	-23.52K	-210K	-448K	768K
Miscellaneous Cash Flow Adjustments	20K	-	-	-	-
Net Change in Cash	636M	-607M	675M	-167M	47.15M
Supplemental Items
Cash Interest Paid	-	31.25M	79.38M	83.02M	73.72M
Levered Free Cash Flow	740M	712M	1.02B	635M	797M
Unlevered Free Cash Flow	776M	761M	1.07B	667M	844M
Change In Net Working Capital	18.77M	69.87M	-125M	167M	20.15M
Net Debt Issued / Repaid	-312M	-430M	-417M	-436M	-402M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	13.69	12.65	13.54	11.64	9.44
Return on Total Capital	19.25	18.04	19.61	17.04	14.05
Return On Equity %	43.96	44.13	46.16	37.93	32.51
Return on Common Equity	43.96	44.13	46.16	37.93	32.51
Margin Analysis
Gross Profit Margin %	36.95	40.23	40.05	39.43	36.43
SG&A Margin	26.25	29.72	29.01	28.68	27.5
EBITDA Margin %	12.86	13.23	13.84	13.55	11.96
EBITA Margin %	11.2	11.23	11.62	11.03	9.23
EBIT Margin %	11.2	11.23	11.6	11.03	9.23
Income From Continuing Operations Margin %	9.82	10.07	10.3	10.24	8.69
Net Income Margin %	9.82	10.07	10.3	10.24	8.69
Net Avail. For Common Margin %	9.82	10.07	10.3	10.24	8.69
Normalized Net Income Margin	6.62	6.49	6.91	6.77	5.5
Levered Free Cash Flow Margin	8.56	8.83	11.86	7.29	8.44
Unlevered Free Cash Flow Margin	8.98	9.44	12.43	7.65	8.93
Asset Turnover
Asset Turnover	1.96	1.8	1.87	1.69	1.64
Fixed Assets Turnover	4.41	3.81	4.01	3.97	3.76
Receivables Turnover (Average Receivables)	73.91	67.56	63.71	57.51	61.27
Inventory Turnover (Average Inventory)	4.71	4.26	4.49	4.07	3.85
Short Term Liquidity
Current Ratio	1.76	1.4	1.7	1.69	1.55
Quick Ratio	0.79	0.42	0.8	0.66	0.54
Operating Cash Flow to Current Liabilities	1.13	1.07	1.11	0.84	0.74
Days Sales Outstanding (Average Receivables)	4.95	5.4	5.73	6.35	5.97
Days Outstanding Inventory (Average Inventory)	77.73	85.76	81.24	89.63	95.09
Average Days Payable Outstanding	31.81	35.23	39.11	50.78	62.18
Cash Conversion Cycle (Average Days)	50.87	55.94	47.86	45.21	38.88
Long Term Solvency
Total Debt/Equity	57.97	84.75	52.07	47.7	59.15
Total Debt / Total Capital	36.7	45.87	34.24	32.3	37.17
LT Debt/Equity	39.88	61.84	35.31	35.35	44.32
Long-Term Debt / Total Capital	25.24	33.47	23.22	23.93	27.85
Total Liabilities / Total Assets	55.3	62.59	54.63	54.15	58.11
EBIT / Interest Expense	16.83	11.48	12.6	19.04	11.82
EBITDA / Interest Expense	25.4	18.42	19.85	30.83	20.99
(EBITDA - Capex) / Interest Expense	20.26	14.84	16.7	23.82	16.39
Total Debt / EBITDA	0.82	0.94	0.74	0.76	0.99
Net Debt / EBITDA	0.13	0.66	0.06	0.17	0.37
Total Debt / (EBITDA - Capex)	1.03	1.16	0.88	0.98	1.27
Net Debt / (EBITDA - Capex)	0.17	0.82	0.07	0.22	0.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	10.47	-6.66	6.82	1.13	8.41
Gross Profit, 1 Yr. Growth %	29.66	1.6	6.33	-1.14	0.17
EBITDA, 1 Yr. Growth %	15.39	-3.89	11.42	-0.97	-4.29
EBITA, 1 Yr. Growth %	16.52	-6.28	10.11	-4.02	-9.27
EBIT, 1 Yr. Growth %	16.6	-6.23	10.36	-3.91	-9.27
Earnings From Cont. Operations, 1 Yr. Growth %	22.7	-4.31	9.27	0.54	-8.05
Net Income, 1 Yr. Growth %	22.7	-4.31	9.27	0.54	-8.05
Normalized Net Income, 1 Yr. Growth %	16.37	-8.55	13.67	-0.9	-11.88
Diluted EPS Before Extra, 1 Yr. Growth %	-93.86	-4.31	9.27	0.54	-8.05
Accounts Receivable, 1 Yr. Growth %	-31.88	42.42	-7.19	32.75	-21.61
Inventory, 1 Yr. Growth %	4.15	-2.82	5.94	19.16	21.39
Net Property, Plant and Equip., 1 Yr. Growth %	0.76	9.63	-6	10.9	17.88
Total Assets, 1 Yr. Growth %	11.08	-8.12	15.35	8.62	14.93
Tangible Book Value, 1 Yr. Growth %	16.46	-23.46	40.84	9.8	4.39
Common Equity, 1 Yr. Growth %	16.5	-22.86	39.9	9.78	5.01
Cash From Operations, 1 Yr. Growth %	17.64	-12.88	25.03	-17.94	13.32
Capital Expenditures, 1 Yr. Growth %	35.73	-4.49	-11.43	41.39	-4.05
Levered Free Cash Flow, 1 Yr. Growth %	-23.57	-5.89	43.49	-38.92	23.51
Unlevered Free Cash Flow, 1 Yr. Growth %	-22.25	-3.94	40.71	-37.77	24.56
Dividend Per Share, 1 Yr. Growth %	-	-	-	3.58	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.45	1.53	-0.15	3.94	4.71
Gross Profit, 2 Yr. CAGR %	25.41	14.77	3.94	2.89	-0.49
EBITDA, 2 Yr. CAGR %	17.47	5.22	3.64	5.04	-2.64
EBITA, 2 Yr. CAGR %	18.69	4.4	1.76	2.8	-6.68
EBIT, 2 Yr. CAGR %	19.32	4.47	1.73	2.98	-6.63
Earnings From Cont. Operations, 2 Yr. CAGR %	17.92	8.36	2.25	4.81	-3.85
Net Income, 2 Yr. CAGR %	17.92	8.36	2.25	4.81	-3.85
Normalized Net Income, 2 Yr. CAGR %	16.66	3.16	1.96	6.13	-6.55
Diluted EPS Before Extra, 2 Yr. CAGR %	-73.63	-78.75	2.25	4.81	-3.85
Accounts Receivable, 2 Yr. CAGR %	-5.4	0.41	14.97	11	2.02
Inventory, 2 Yr. CAGR %	2.14	-0.77	1.47	12.36	20.27
Net Property, Plant and Equip., 2 Yr. CAGR %	83.66	6.49	1.51	2.1	14.33
Total Assets, 2 Yr. CAGR %	31.51	1.19	2.95	11.94	11.73
Tangible Book Value, 2 Yr. CAGR %	11.5	-5.58	3.83	24.36	7.06
Common Equity, 2 Yr. CAGR %	11.27	-5.2	3.88	23.93	7.37
Cash From Operations, 2 Yr. CAGR %	27.21	1.24	2.55	1.29	-5.44
Capital Expenditures, 2 Yr. CAGR %	34.93	13.86	-8.03	11.91	16.48
Levered Free Cash Flow, 2 Yr. CAGR %	13.76	-14.25	16.2	-5.56	-12.42
Unlevered Free Cash Flow, 2 Yr. CAGR %	16.49	-12.67	16.26	-6.43	-11.27
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	1.77
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7	3.15	3.26	0.27	5.41
Gross Profit, 3 Yr. CAGR %	15.75	16.91	11.89	2.46	1.97
EBITDA, 3 Yr. CAGR %	7.9	9.81	7.36	2.08	1.84
EBITA, 3 Yr. CAGR %	7.41	9.63	6.39	-0.21	-1.39
EBIT, 3 Yr. CAGR %	8.26	10.04	6.4	-0.19	-1.28
Earnings From Cont. Operations, 3 Yr. CAGR %	5.59	9.99	8.66	1.68	0.34
Net Income, 3 Yr. CAGR %	5.59	9.99	8.66	1.68	0.34
Normalized Net Income, 3 Yr. CAGR %	6.8	7.56	6.55	1	-0.25
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-62.87	-63.32	1.68	0.34
Accounts Receivable, 3 Yr. CAGR %	-4.22	9.82	-2.19	20.62	-1.15
Inventory, 3 Yr. CAGR %	-1.26	-0.46	1.42	7.05	15.29
Net Property, Plant and Equip., 3 Yr. CAGR %	37.12	56	2.15	4.55	7.11
Total Assets, 3 Yr. CAGR %	21.83	16.82	5.71	4.8	12.93
Tangible Book Value, 3 Yr. CAGR %	8.77	-1.64	7.88	5.78	17.31
Common Equity, 3 Yr. CAGR %	8.5	-1.52	7.93	5.81	17.27
Cash From Operations, 3 Yr. CAGR %	20.31	12.13	7.35	-4.79	3.79
Capital Expenditures, 3 Yr. CAGR %	20.82	20.25	4.71	6.15	6.31
Levered Free Cash Flow, 3 Yr. CAGR %	-	7.58	1.8	-5.67	3.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	10	2.38	-5.6	3.48
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	4.07	3.46	3.84
Gross Profit, 5 Yr. CAGR %	-	-	10.87	11.09	6.91
EBITDA, 5 Yr. CAGR %	-	-	6.14	7.94	3.24
EBITA, 5 Yr. CAGR %	-	-	5.08	6.92	0.95
EBIT, 5 Yr. CAGR %	-	-	5.56	7.16	0.98
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	4.24	7.89	3.47
Net Income, 5 Yr. CAGR %	-	-	4.24	7.89	3.47
Normalized Net Income, 5 Yr. CAGR %	-	-	4.83	6.99	1.1
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-43.77	-46.07
Accounts Receivable, 5 Yr. CAGR %	-	-	3.83	10.29	-0.53
Inventory, 5 Yr. CAGR %	-	-	-0.72	4.48	8.57
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	22.22	31.67	6.86
Total Assets, 5 Yr. CAGR %	-	-	13.97	14.84	8.08
Tangible Book Value, 5 Yr. CAGR %	-	-	6.77	8.03	7.55
Common Equity, 5 Yr. CAGR %	-	-	6.63	7.96	7.7
Cash From Operations, 5 Yr. CAGR %	-	-	12.86	6.91	2.04
Capital Expenditures, 5 Yr. CAGR %	-	-	8.33	16.84	9.27
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	2.12	-3.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	3.11	-3.31